5 Years of END7: Thank You
We launched the award-winning END7 campaign in 2012 to build a grassroots movement to end the seven most common neglected tropical diseases (NTDs). With your support, we mobilized funding to support programs that treated more than 50 million people, helped increase US and UK funding for NTDs and spread awareness of the global NTD burden. Now, five years later, we are concluding the END7 campaign. We are grateful for the support of all of our followers, student groups and generous donors who made the campaign such a success.
Stay involved in the fight against neglected tropical diseases (NTDs) – join and support these initiatives led by our partners around the globe:
Uniting to Combat NTDs is a partnership of private and public sector organizations working together to defeat 10 NTDs and improve the lives of a billion people. Stay updated with news about NTDs and the amazing progress partners are making across the globe by subscribing to Uniting’s e-newsletter and following Uniting on Twitter!
Looking for a way to continue raising funds for and awareness of NTDs? Consider joining the END Fund for your next adventure! In the past, teams have taken on climbing Mt. Kilimanjaro and pushing themselves to finish the Victoria Falls marathon and half marathon. Contact Abbey Turtinen for more information.
The Carter Center has built hope for millions of the world’s poorest people by distributing more than 500 million doses of donated medication to combat five NTDs in Africa and Latin America. You can help them build hope for millions more by making a donation.
The Global Schistosomiasis Alliance is a coalition of NGOs, development agencies, research institutions and the private sector targeting the debilitating NTD schistosomiasis working to advocate, coordinate and facilitate the necessary networks and activities to reach the WHO's target for schistosomiasis control and elimination. Learn more on their website, sign up for their newsletter and follow them on Twitter and Facebook.
Sightsavers is an international organization that changes lives for the long term. They work to eliminate avoidable blindness and support people with visual impairments to live independently. This includes work with partners to support programs in 29 countries targeting five NTDs. In 2016 Sightsavers supported a record number of treatments: more than 154 million. Follow @Sightsavers and @SightsaversUSA on Twitter or like Sightsavers on Facebook to share posts and show your support.
Every two minutes someone is diagnosed with leprosy and more than 4 million people suffer from lifelong disabilities caused by this devastating neglected tropical disease. Although leprosy can be cured, there is no vaccine to prevent it. But finally, after 15 years of research and development, the world's first leprosy-specific vaccine is ready for Phase I clinical trials. Donate now to American Leprosy Missions stop the suffering and help end this ancient disease once and for all.
PATH is developing treatments for NTDs to make more lifesaving medicines available and add new tools to the fight against drug resistance. Learn more about how PATH is working with countries and partners worldwide to find the best ways to deploy the NTD-fighting tools we already have, advance new tools and tackle the root causes of infection so that children and communities can thrive.
The London Centre for NTD Research is an innovative research collaboration that brings together over 200 NTD experts from leading research institutions based in London undertaking cutting-edge research to build the evidence base around the design, implementation and evaluation of NTD control and elimination programs. Visit their NTD research directory, sign up for their research newsletter and follow @NTDresearch to learn more.
CaringCrowd® is an award-winning crowdfunding platform proudly sponsored by Johnson & Johnson that is dedicated to supporting community health projects (including ones addressing NTDs) anywhere in the world. Every project on the platform is sponsored by a non-profit and has been reviewed by a team of experts. There are many ways you can get involved, from pledging, to posting a campaign, or advocating for a cause you support. Visit www.CaringCrowd.org or contact email@example.com to get started.
With the help of our supporters, the END7 campaign achieved amazing things – mobilizing funding to treat more than 50 million people, raising the volume of global advocacy and building a movement to end the suffering caused by NTDs. The Sabin Vaccine Institute remains committed to improving health around the world through our renewed focus on immunization. We are deeply grateful for everyone’s commitment and contributions to the END7 campaign!